Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression
- PMID: 17401528
- DOI: 10.1007/s00702-007-0705-9
Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression
Abstract
Several studies have linked 5-HT1A C1019G and BDNF G196A (Val66Met) gene polymorphisms to major depressive disorder (MDD) and the actions of antidepressants. We attempt to show that the interaction between 5-HT1A and BDNF polymorphism predicts the risk of treatment-resistant depression. The sample consists of 119 patients with treatment-resistant MDD and 392 controls. 5-HT1A C1019G and BDNF G196A (Val66Met) polymorphisms were studied. The combination of 5-HT1A GG and BDNF GA + AA genotypes is associated with an increased risk of depression.
Similar articles
-
Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.Brain Res. 2006 Nov 6;1118(1):176-82. doi: 10.1016/j.brainres.2006.08.012. Epub 2006 Sep 18. Brain Res. 2006. PMID: 16979146
-
The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.Neuroreport. 2007 Aug 6;18(12):1291-3. doi: 10.1097/WNR.0b013e328273bcb0. Neuroreport. 2007. PMID: 17632285 Free PMC article.
-
Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor binding.PLoS One. 2014 Sep 4;9(9):e106810. doi: 10.1371/journal.pone.0106810. eCollection 2014. PLoS One. 2014. PMID: 25188405 Free PMC article.
-
Neuroimaging genetics: new perspectives in research on major depression?Acta Psychiatr Scand. 2008 Nov;118(5):363-72. doi: 10.1111/j.1600-0447.2008.01225.x. Epub 2008 Jul 14. Acta Psychiatr Scand. 2008. PMID: 18644006 Review.
-
Transcriptional regulation at a HTR1A polymorphism associated with mental illness.Neuropharmacology. 2008 Nov;55(6):977-85. doi: 10.1016/j.neuropharm.2008.06.046. Epub 2008 Jun 29. Neuropharmacology. 2008. PMID: 18639564 Review.
Cited by
-
The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.Mol Psychiatry. 2015 Aug;20(8):916-30. doi: 10.1038/mp.2015.27. Epub 2015 Mar 31. Mol Psychiatry. 2015. PMID: 25824305 Review.
-
Is there Progress? An Overview of Selecting Biomarker Candidates for Major Depressive Disorder.Front Psychiatry. 2016 Apr 25;7:72. doi: 10.3389/fpsyt.2016.00072. eCollection 2016. Front Psychiatry. 2016. PMID: 27199779 Free PMC article. Review.
-
The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.J Psychiatr Res. 2013 Jan;47(1):8-14. doi: 10.1016/j.jpsychires.2012.10.003. Epub 2012 Nov 6. J Psychiatr Res. 2013. PMID: 23137999 Free PMC article.
-
Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness.Mol Brain. 2011 May 27;4:21. doi: 10.1186/1756-6606-4-21. Mol Brain. 2011. PMID: 21619616 Free PMC article. Review.
-
Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications.CNS Drugs. 2014 Jan;28(1):1-10. doi: 10.1007/s40263-013-0119-1. CNS Drugs. 2014. PMID: 24150993 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources